Company or institution

Arog Pharmaceuticals, Inc.

Save Like

46 applicationsfiled 2013 to 2026

Allowance rate

77%

+2 pts vs the USPTO range 62% to 87%

Rejections before allowance

1.6

level with the USPTO

Months to first action

15.2 mo

−3.4 vs the USPTO

Needed an RCE

21%

−7 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations37 apps

C12Q Measuring or testing processes involving enzymes or nucleic acids5 apps

C07D Heterocyclic compounds3 apps

A61P Therapeutic activity of compounds1 apps

Art units

162911 apps

16155 apps

16275 apps

OPAP5 apps

16214 apps

16224 apps

Examiners met

The examiners seen most, and how it went with each

Shirley V Gembeh8 apps

100%

Docket Central5 apps

n/a

Carla J Myers5 apps

80%

Shengjun Wang5 apps

100%

Kevin E Weddington5 apps

80%

Raymond J Henley III4 apps

50%

Paul V Ward3 apps

100%

Valerie Rodriguez-Garcia2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

CHALKER FLORES, LLP43 apps

76%

FOLEY HOAG, LLP (General)3 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19714739	CRENOLANIB FOR TREATING FLT3 MUTATED PROLIFERATIVE DISORDERS ASSOCIATED MUTATIONS	2026-06-22	Pending	0	0	n/a
19714088	CRENOLANIB FOR TREATING FLT3 MUTATED PROLIFERATIVE DISORDERS ASSOCIATED MUTATIONS	2026-06-19	Pending	0	0	n/a
19384664	CRYSTAL FORMS OF CRENOLANIB AND METHODS OF USE THEREOF	2025-11-10	Pending	0	0	n/a
15298930	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15273968	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15720799	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15998937	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15125546	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15807439	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15489879	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 46 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in